Monoclonal Antibodies in Cancer Therapy: Mechanisms, Successes and Limitations

被引：46
|
作者：
Coulson, A. [1 ]
Levy, A. [1 ]
Gossell-Williams, M. [1 ]
机构：
[1] Univ W Indies, Dept Basic Med Sci, Pharmacol Sect, Kingston 7, Jamaica
来源：
WEST INDIAN MEDICAL JOURNAL | 2014年 / 63卷 / 06期
关键词：
Antigenic targets; cancer therapy; clinical benefits; monoclonal antibodies; CHRONIC LYMPHOCYTIC-LEUKEMIA; BRENTUXIMAB VEDOTIN; COLORECTAL-CANCER; LYMPHOMA; RITUXIMAB; CHEMOTHERAPY; RADIOIMMUNOTHERAPY; TRASTUZUMAB; BEVACIZUMAB; INDUCTION;
D O I：
10.7727/wimj.2013.241
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Rituximab was the first chemotherapeutic monoclonal antibody (CmAb) approved for clinical use in cancer therapeutics in 1997 and has significantly improved the clinical outcomes in non-Hodgkin's lymphoma. Since then, numerous CmAbs have been developed and approved for the treatment of various haematologic and solid human cancers. In this review, the classification, efficacy and significantly reduced toxicity of CmAbs available for use in the United States of America are presented. Finally, the limitations of CmAbs and future considerations are explored.
引用
收藏
页码：650 / 654
页数：5
相关论文
共 50 条
  • [1] Successes and Limitations of Targeted Cancer Therapy in Lung Cancer
    Suda, Kenichi
    Mitsudomi, Tetsuya
    SUCCESSES AND LIMITATIONS OF TARGETED CANCER THERAPY, 2014, 41 : 62 - 77
  • [2] Successes and Limitations of Targeted Cancer Therapy in Ovarian Cancer
    Damia, Giovanna
    Sessa, Cristiana
    SUCCESSES AND LIMITATIONS OF TARGETED CANCER THERAPY, 2014, 41 : 89 - 97
  • [3] Successes and Limitations of Targeted Cancer Therapy in Colon Cancer
    Koehne, Claus-Henning
    SUCCESSES AND LIMITATIONS OF TARGETED CANCER THERAPY, 2014, 41 : 36 - 50
  • [4] Successes and Limitations of Targeted Cancer Therapy in Breast Cancer
    Curigliano, Giuseppe
    Criscitiello, Carmen
    SUCCESSES AND LIMITATIONS OF TARGETED CANCER THERAPY, 2014, 41 : 15 - 35
  • [5] Successes and Limitations of Targeted Cancer Therapy in Melanoma
    Romano, Emanuela
    Michielin, Olivier
    SUCCESSES AND LIMITATIONS OF TARGETED CANCER THERAPY, 2014, 41 : 78 - 88
  • [6] Monoclonal Antibodies in Cancer Therapy
    Zahavi, David
    Weiner, Louis
    ANTIBODIES, 2020, 9 (03) : 1 - 20
  • [7] Monoclonal antibodies for the therapy of cancer
    Andrew Simpson
    Otavia Caballero
    BMC Proceedings, 8 (Suppl 4)
  • [8] Monoclonal antibodies in cancer therapy
    Gruber, R
    Holz, E
    Riethmuller, G
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1996, 18 (02): : 243 - 251
  • [9] Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
    Rodriguez-Nava, Cynthia
    Ortuno-Pineda, Carlos
    Illades-Aguiar, Berenice
    Flores-Alfaro, Eugenia
    Leyva-Vazquez, Marco Antonio
    Parra-Rojas, Isela
    del Moral-Hernandez, Oscar
    Vences-Velazquez, Amalia
    Cortes-Sarabia, Karen
    del Carmen Alarcon-Romero, Luz
    BIOMEDICINES, 2023, 11 (06)
  • [10] Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
    Berois, Nora
    Pittini, Alvaro
    Osinaga, Eduardo
    CANCERS, 2022, 14 (03)
12345